Quantcast
Last updated on April 19, 2014 at 5:20 EDT

Elsevier Honored as “The Most Influential Publisher of the Last 100 Years in BioMedicine and the Life Sciences” by the Special Libraries Association

June 17, 2009

AMSTERDAM, June 17 /PRNewswire-FirstCall/ –

– SLA Centennial Observance Chooses 20 Elsevier Journals Among 100 Most
Influential Journals in Past Century

Elsevier has been awarded the “The Most Influential Publisher of the Last
100 Years in BioMedicine and the Life Sciences” at the Special Library
Association’s (SLA) Centennial conference on Tuesday, June 16th in Washington
DC
. Twenty journals published by Elsevier, many on behalf of renowned
societies, were also selected as the SLA’s Top 100 Journals in Biology and
Medicine.

Established in 1909 to serve librarians specialized in business,
government, social agencies, and academia, the SLA is now an 11,000-member
professional organization of subject specialist librarians, information
managers, and publishing industry representatives. Each topical division has
contributed a Centennial-themed event throughout the year. In 2008, DBIO
convened an international panel of nine eminent subject experts to compile a
ballot for an electronic poll of SLA members concerning the most influential
publisher and the 100 most influential journals of biology and medicine over
the past century of SLA’s existence.

“Elsevier won as the most influential publisher of the last 100 years
because time and time again it has been brave, bold, and collaborative,”
remarked Tony Stankus, Director, BioMedical & Life Sciences Division at the
Special Libraries Association, “Whenever Elsevier saw real value, they went
after it boldly. Elsevier’s acquisition of the Cell Press titles and the
Lancet are living proof that important titles are well worth buying and
building upon. Elsevier knows how to develop a working relationship with
scientific and clinical societies. It is my sincere hope that Elsevier
continues to be brave, bold, and collaborative as it works with libraries in
these economically challenging, yet scientifically exciting and clinically
promising times.”

“While Elsevier is greatly honored to be recognized by the SLA, we see
the publisher’s role as that of a long term supporting actor to the
researchers. They are the ones who make the discoveries that advance science
and bring journals to life as authors, editors, and reviewers,” remarked

Youngsuk “Y.S.” Chi, Vice Chairman at Elsevier, who accepted the honor at the
June 16th award ceremony, “Elsevier will use this honor to reaffirm our
passion for excellence as we continue to serve the needs of the research
community.”

The DBIO 100, the 100 Most Influential Journals in Biology & Medicine
over the last 100 Years as voted by the BioMedical & Life Sciences Division
of the Special Libraries Association on the Occasion of its Centennial
include twenty Elsevier journals, many published in partnership with
prestigious societies:

    - The American Journal of Human Genetics Cell Press with the American
      Society of Human Genetics

    - American Journal of Obstetrics & Gynecology Elsevier with the American
      Gynecological and Obstetrical Society

    - Animal Behaviour Elsevier with the Association for the Study of Animal
      Behaviour, UK, and the Animal Behavior Society US

    - Annals of Emergency Medicine Elsevier with the American College of
      Emergency Physicians (http://www.acep.org/)

    - Archives of Physical Medicine and Rehabilitation Elsevier with the
      American Congress of Rehabilitation

    - Biochimica et Biophysica Acta, Elsevier

    - Brain and Cognition, Elsevier together with several US and
      international cognitive neuropsychology societies

    - Cell, Cell Press, Elsevier

    - Current Biology, Cell Press, Elsevier

    - Developmental Biology Elsevier with the Society for Developmental
      Biology

    - Gastroenterology, Elsevier with the American Gastroenterological
      Association

    - The Journal of Allergy and Clinical Immunology, Elsevier with
      the American Academy of Allergy, Asthma and Immunology

    - Journal of Experimental Marine Biology and Ecology, Elsevier

    - Journal of Human Evolution Elsevier

    - Journal of Molecular Biology Elsevier

    - Journal of the American Academy of Dermatology Elsevier with the
      American Academy of Dermatology

    - Journal of the American College of Surgeons Elsevier with the American
      College of Surgeons

    - The Journal of Urology Elsevier with the American Urological
      Association

    - The Lancet Elsevier

    - Virology Elsevier

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. Working in partnership with the
global science and health communities, Elsevier’s 7,000 employees in over 70
offices worldwide publish more than 2,000 journals and 1,900 new books per
year, in addition to offering a suite of innovative electronic products, such
as ScienceDirect (http://www.sciencedirect.com/), MD Consult
(http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/),
bibliographic databases, and online reference works.

Elsevier (http://www.elsevier.com/) is a global business headquartered in
Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of
Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading
publisher and information provider. Operating in the science and medical,
legal, education and business-to-business sectors, Reed Elsevier provides
high-quality and flexible information solutions to users, with increasing
emphasis on the Internet as a means of delivery. Reed Elsevier’s ticker
symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and
ENL (New York Stock Exchange).

    Ylann Schemm
    Phone +31-20-485-2025
    E-mail newsroom@elsevier.com

SOURCE Elsevier


Source: newswire